Cargando…
The immune-metabolic crosstalk between CD3(+)C1q(+)TAM and CD8(+)T cells associated with relapse-free survival in HCC
INTRODUCTION: Although multiple targeted treatments have appeared, hepatocellular carcinoma (HCC) is still one of the most common causes of cancer-related deaths. The immunosuppressive tumor microenvironment (TME) is a critical factor in the oncogenesis and progression of HCC. The emerging scRNA-seq...
Autores principales: | , , , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9948089/ https://www.ncbi.nlm.nih.gov/pubmed/36845133 http://dx.doi.org/10.3389/fimmu.2023.1033497 |
_version_ | 1784892702124408832 |
---|---|
author | Yang, Yanying Sun, Lu Chen, Zhouyi Liu, Weiren Xu, Qiyue Liu, Fangming Ma, Mingyue Chen, Yuwen Lu, Yan Fang, Hao Chen, Geng Shi, Yinghong Wu, Duojiao |
author_facet | Yang, Yanying Sun, Lu Chen, Zhouyi Liu, Weiren Xu, Qiyue Liu, Fangming Ma, Mingyue Chen, Yuwen Lu, Yan Fang, Hao Chen, Geng Shi, Yinghong Wu, Duojiao |
author_sort | Yang, Yanying |
collection | PubMed |
description | INTRODUCTION: Although multiple targeted treatments have appeared, hepatocellular carcinoma (HCC) is still one of the most common causes of cancer-related deaths. The immunosuppressive tumor microenvironment (TME) is a critical factor in the oncogenesis and progression of HCC. The emerging scRNA-seq makes it possible to explore the TME at a high resolution. This study was designed to reveal the immune-metabolic crosstalk between immune cells in HCC and provide novel strategies to regulate immunosuppressive TME. METHOD: In this study, we performed scRNA-seq on paired tumor and peri-tumor tissues of HCC. The composition and differentiation trajectory of the immune populations in TME were portrayed. Cellphone DB was utilized to calculate interactions between the identified clusters. Besides, flow cytometry, RT-PCR and seahorse experiments were implemented to explore potential metabolic and epigenetic mechanisms of the inter-cellular interaction. RESULT: A total of 19 immune cell clusters were identified and 7 were found closely related to HCC prognosis. Besides, differentiation trajectories of T cells were also presented. Moreover, a new population, CD3+C1q+ tumor-associated macrophages (TAM) were identified and found significantly interacted with CD8+ CCL4+T cells. Compared to the peri-tumor tissue, their interaction was attenuated in tumor. Additionally, the dynamic presence of this newly found cluster was also verified in the peripheral blood of patients with sepsis. Furthermore, we found that CD3+C1q+TAM affected T cell immunity through C1q signaling-induced metabolic and epigenetic reprogramming, thereby potentially affecting tumor prognosis. CONCLUSION: Our study revealed the interaction between CD3+C1q+TAM and CD8+ CCL4+T cells and may provide implications for tackling the immunosuppressive TME in HCC. |
format | Online Article Text |
id | pubmed-9948089 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2023 |
publisher | Frontiers Media S.A. |
record_format | MEDLINE/PubMed |
spelling | pubmed-99480892023-02-24 The immune-metabolic crosstalk between CD3(+)C1q(+)TAM and CD8(+)T cells associated with relapse-free survival in HCC Yang, Yanying Sun, Lu Chen, Zhouyi Liu, Weiren Xu, Qiyue Liu, Fangming Ma, Mingyue Chen, Yuwen Lu, Yan Fang, Hao Chen, Geng Shi, Yinghong Wu, Duojiao Front Immunol Immunology INTRODUCTION: Although multiple targeted treatments have appeared, hepatocellular carcinoma (HCC) is still one of the most common causes of cancer-related deaths. The immunosuppressive tumor microenvironment (TME) is a critical factor in the oncogenesis and progression of HCC. The emerging scRNA-seq makes it possible to explore the TME at a high resolution. This study was designed to reveal the immune-metabolic crosstalk between immune cells in HCC and provide novel strategies to regulate immunosuppressive TME. METHOD: In this study, we performed scRNA-seq on paired tumor and peri-tumor tissues of HCC. The composition and differentiation trajectory of the immune populations in TME were portrayed. Cellphone DB was utilized to calculate interactions between the identified clusters. Besides, flow cytometry, RT-PCR and seahorse experiments were implemented to explore potential metabolic and epigenetic mechanisms of the inter-cellular interaction. RESULT: A total of 19 immune cell clusters were identified and 7 were found closely related to HCC prognosis. Besides, differentiation trajectories of T cells were also presented. Moreover, a new population, CD3+C1q+ tumor-associated macrophages (TAM) were identified and found significantly interacted with CD8+ CCL4+T cells. Compared to the peri-tumor tissue, their interaction was attenuated in tumor. Additionally, the dynamic presence of this newly found cluster was also verified in the peripheral blood of patients with sepsis. Furthermore, we found that CD3+C1q+TAM affected T cell immunity through C1q signaling-induced metabolic and epigenetic reprogramming, thereby potentially affecting tumor prognosis. CONCLUSION: Our study revealed the interaction between CD3+C1q+TAM and CD8+ CCL4+T cells and may provide implications for tackling the immunosuppressive TME in HCC. Frontiers Media S.A. 2023-02-09 /pmc/articles/PMC9948089/ /pubmed/36845133 http://dx.doi.org/10.3389/fimmu.2023.1033497 Text en Copyright © 2023 Yang, Sun, Chen, Liu, Xu, Liu, Ma, Chen, Lu, Fang, Chen, Shi and Wu https://creativecommons.org/licenses/by/4.0/This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms. |
spellingShingle | Immunology Yang, Yanying Sun, Lu Chen, Zhouyi Liu, Weiren Xu, Qiyue Liu, Fangming Ma, Mingyue Chen, Yuwen Lu, Yan Fang, Hao Chen, Geng Shi, Yinghong Wu, Duojiao The immune-metabolic crosstalk between CD3(+)C1q(+)TAM and CD8(+)T cells associated with relapse-free survival in HCC |
title | The immune-metabolic crosstalk between CD3(+)C1q(+)TAM and CD8(+)T cells associated with relapse-free survival in HCC |
title_full | The immune-metabolic crosstalk between CD3(+)C1q(+)TAM and CD8(+)T cells associated with relapse-free survival in HCC |
title_fullStr | The immune-metabolic crosstalk between CD3(+)C1q(+)TAM and CD8(+)T cells associated with relapse-free survival in HCC |
title_full_unstemmed | The immune-metabolic crosstalk between CD3(+)C1q(+)TAM and CD8(+)T cells associated with relapse-free survival in HCC |
title_short | The immune-metabolic crosstalk between CD3(+)C1q(+)TAM and CD8(+)T cells associated with relapse-free survival in HCC |
title_sort | immune-metabolic crosstalk between cd3(+)c1q(+)tam and cd8(+)t cells associated with relapse-free survival in hcc |
topic | Immunology |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9948089/ https://www.ncbi.nlm.nih.gov/pubmed/36845133 http://dx.doi.org/10.3389/fimmu.2023.1033497 |
work_keys_str_mv | AT yangyanying theimmunemetaboliccrosstalkbetweencd3c1qtamandcd8tcellsassociatedwithrelapsefreesurvivalinhcc AT sunlu theimmunemetaboliccrosstalkbetweencd3c1qtamandcd8tcellsassociatedwithrelapsefreesurvivalinhcc AT chenzhouyi theimmunemetaboliccrosstalkbetweencd3c1qtamandcd8tcellsassociatedwithrelapsefreesurvivalinhcc AT liuweiren theimmunemetaboliccrosstalkbetweencd3c1qtamandcd8tcellsassociatedwithrelapsefreesurvivalinhcc AT xuqiyue theimmunemetaboliccrosstalkbetweencd3c1qtamandcd8tcellsassociatedwithrelapsefreesurvivalinhcc AT liufangming theimmunemetaboliccrosstalkbetweencd3c1qtamandcd8tcellsassociatedwithrelapsefreesurvivalinhcc AT mamingyue theimmunemetaboliccrosstalkbetweencd3c1qtamandcd8tcellsassociatedwithrelapsefreesurvivalinhcc AT chenyuwen theimmunemetaboliccrosstalkbetweencd3c1qtamandcd8tcellsassociatedwithrelapsefreesurvivalinhcc AT luyan theimmunemetaboliccrosstalkbetweencd3c1qtamandcd8tcellsassociatedwithrelapsefreesurvivalinhcc AT fanghao theimmunemetaboliccrosstalkbetweencd3c1qtamandcd8tcellsassociatedwithrelapsefreesurvivalinhcc AT chengeng theimmunemetaboliccrosstalkbetweencd3c1qtamandcd8tcellsassociatedwithrelapsefreesurvivalinhcc AT shiyinghong theimmunemetaboliccrosstalkbetweencd3c1qtamandcd8tcellsassociatedwithrelapsefreesurvivalinhcc AT wuduojiao theimmunemetaboliccrosstalkbetweencd3c1qtamandcd8tcellsassociatedwithrelapsefreesurvivalinhcc AT yangyanying immunemetaboliccrosstalkbetweencd3c1qtamandcd8tcellsassociatedwithrelapsefreesurvivalinhcc AT sunlu immunemetaboliccrosstalkbetweencd3c1qtamandcd8tcellsassociatedwithrelapsefreesurvivalinhcc AT chenzhouyi immunemetaboliccrosstalkbetweencd3c1qtamandcd8tcellsassociatedwithrelapsefreesurvivalinhcc AT liuweiren immunemetaboliccrosstalkbetweencd3c1qtamandcd8tcellsassociatedwithrelapsefreesurvivalinhcc AT xuqiyue immunemetaboliccrosstalkbetweencd3c1qtamandcd8tcellsassociatedwithrelapsefreesurvivalinhcc AT liufangming immunemetaboliccrosstalkbetweencd3c1qtamandcd8tcellsassociatedwithrelapsefreesurvivalinhcc AT mamingyue immunemetaboliccrosstalkbetweencd3c1qtamandcd8tcellsassociatedwithrelapsefreesurvivalinhcc AT chenyuwen immunemetaboliccrosstalkbetweencd3c1qtamandcd8tcellsassociatedwithrelapsefreesurvivalinhcc AT luyan immunemetaboliccrosstalkbetweencd3c1qtamandcd8tcellsassociatedwithrelapsefreesurvivalinhcc AT fanghao immunemetaboliccrosstalkbetweencd3c1qtamandcd8tcellsassociatedwithrelapsefreesurvivalinhcc AT chengeng immunemetaboliccrosstalkbetweencd3c1qtamandcd8tcellsassociatedwithrelapsefreesurvivalinhcc AT shiyinghong immunemetaboliccrosstalkbetweencd3c1qtamandcd8tcellsassociatedwithrelapsefreesurvivalinhcc AT wuduojiao immunemetaboliccrosstalkbetweencd3c1qtamandcd8tcellsassociatedwithrelapsefreesurvivalinhcc |